Author

Douglas J. Padley

Observed names: D J Padley, D Padley, D. J. Padley, D. Padley, D.J. Padley, Douglas J Padley, Douglas Padley, Douglas J. Padley

Observed institutions: University of Iowa, Mayo Clinic, University of Iowa Hospitals and Clinics, University of Iowa Health Care

OpenAlex ID: A5110097689

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

2000 · P A Burch, J K Breen, et al. · PubMed · 263

Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability

2010 · Ruben Crespo-Diaz, Atta Behfar, et al. · Cell Transplantation · 233

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

2002 · Scott E Strome, Stephen Voss, et al. · PubMed · 154

Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery

1996 · H Kook, F Goldman, et al. · Blood · 141

PDF

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

2018 · Kimberly R. Kalli, Matthew S. Block, et al. · Clinical Cancer Research · 102

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

2004 · L F Porrata, M A Gertz, et al. · Leukemia · 97

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

2003 · L F Porrata, M R Litzow, et al. · Bone Marrow Transplantation · 97

Idiotype‐pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

2009 · Martha Q. Lacy, Sumithra Mandrekar, et al. · American Journal of Hematology · 92

PDF

Re-infused Autologous Graft Natural Killer Cells Correlates with Absolute Lymphocyte Count Recovery after Autologous Stem Cell Transplantation

2003 · Luis F. Porrata, Dennis A. Gastineau, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 67

AMD3100 Affects Autograft Lymphocyte Collection and Progression-Free Survival After Autologous Stem Cell Transplantion in Non-Hodgkin Lymphoma

2007 · Shernan G. Holtan, Luis F. Porrata, et al. · Clinical Lymphoma & Myeloma · 59

Infrastructure Development for Human Cell Therapy Translation

2007 · A B Dietz, D J Padley, et al. · Clinical Pharmacology & Therapeutics · 48

Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations

1996 · D. J. Padley, F. P. Koontz, et al. · Transfusion · 46

Sterility testing of hematopoietic progenitor cell products: a single‐institution series of culture‐positive rates and successful infusion of culture‐positive products

2007 · Douglas J. Padley, Allan B. Dietz, et al. · Transfusion · 35

A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting P hase I human trials

2014 · Bingkun K. Chen, Nathan P. Staff, et al. · Transfusion · 33

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

2006 · Svetomir N Markovic, Allan B Dietz, et al. · Journal of Translational Medicine · 29

PDF

Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML

2006 · M.R. Litzow, A.B. Dietz, et al. · Cytotherapy · 26

Mature Myeloid Dendritic Cells for Clinical Use Prepared from CD14 + Cells Isolated by Immunomagnetic Adsorption

2001 · Douglas J. Padley, Allan B. Dietz, et al. · Stem Cells and Development · 22

Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma

2004 · A.B. Dietz, D.J. Padley, et al. · Cytotherapy · 21

Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation.

1989 · M E Trigg, R Gingrich, et al. · PubMed · 21

Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine

2019 · Keith L. Knutson, Matthew S. Block, et al. · Clinical Cancer Research · 19

Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target

2006 · R Katipamula, L F Porrata, et al. · Bone Marrow Transplantation · 15

Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy

2003 · D.J. Padley, C.W. Greiner, et al. · Cytotherapy · 15

Discordant CD 34+ cell results in peripheral blood and hematopoietic progenitor cell–apheresis product: implications for clinical decisions and impact on patient treatment

2013 · Courtney J. Liwski, Douglas J. Padley, et al. · Transfusion · 5

Effect of AMD3100 on T Lymphocyte Subpopulations in Apheresis Products of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Non Hodgkin Lymphoma.

2005 · Shernan G. Holtan, Luis F. Porrata, et al. · Blood · 3

Increasing the Number of Apheresis Collections Increases Lymphocyte Collection and Affects Survival after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

2004 · Luis F. Porrata, Dennis A. Gastineau, et al. · Blood · 3

Works count: 40

Citation count: 1,649

H-index: 19

I10-index: 22